World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
36636
World Ranking
10778
National Ranking
5543

Javid Moslehi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Javid Moslehi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 285 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Javid Moslehi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Javid Moslehi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Javid Moslehi is affiliated with the University of California, San Francisco in the United States. Their research broadly spans the field of Medicine, with a focus on Oncology and Cardiology and Cardiovascular Medicine, as well as Molecular Biology, Immunology, and Genetics.

Their recent scholarly contributions include papers published between 2020 and 2022 in notable journals. These include:

  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS), 2022, European Heart Journal
  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations, 2020, Annals of Oncology
  • Immune-checkpoint inhibitors: long-term implications of toxicity, 2022, Nature Reviews Clinical Oncology
  • Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy, 2020, Circulation Heart Failure
  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society, 2020, European Journal of Heart Failure

Their frequent co-authors include Joe-Elie Salem, Stéphane Éderhy, Douglas B. Johnson, Juan Qin, and Lorenz Lehmann, reflecting a collaborative network in both oncology and cardiology research.

Javid Moslehi's work has been published extensively in several venues, with the highest numbers of publications in:

  • Circulation (22 publications)
  • Circulation Research (12 publications)
  • European Heart Journal (9 publications)
  • Journal of Clinical Oncology (8 publications)
  • JACC CardioOncology (7 publications)

Their main fields of study total 426 publications, with subfields distributed as 152 in Oncology, 107 in Cardiology and Cardiovascular Medicine, 31 in Molecular Biology, 29 in Immunology, and 25 in Genetics.

The primary topics researched by Moslehi include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Viral Infections and Immunology Research
  • Chronic Lymphocytic Leukemia Research
  • Peptidase Inhibition and Analysis
  • Cardiac Imaging and Diagnostics

Best Publications

  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade

    Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

  • Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

    Daniel Y. Wang;Joe Elie Salem;Joe Elie Salem;Justine V. Cohen;Sunandana Chandra

  • Declining NAD + Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging

    Ana P. Gomes;Ana P. Gomes;Nathan L. Price;Alvin J.Y. Ling;Javid Moslehi

  • Telomere dysfunction induces metabolic and mitochondrial compromise

    Ergiin Sahin;Simona Colla;Marc Liesa;Javid Moslehi

  • MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

    Syed S. Mahmood;Michael G. Fradley;Justine V. Cohen;Anju Nohria

  • Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline

    Saro H. Armenian;Saro H. Armenian;Christina Lacchetti;Ana Barac;Joseph Carver

  • Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

    Joe-Elie Salem;Joe-Elie Salem;Ali Manouchehri;Melissa Moey;Bénédicte Lebrun-Vignes

  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    Giuseppe Curigliano;Daniel J. Lenihan;Michael G. Fradley;Sarju Ganatra

  • Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

    Javid J. Moslehi;Joe Elie Salem;Jeffrey A. Sosman;Bénédicte Lebrun-Vignes

  • Cardiovascular Toxic Effects of Targeted Cancer Therapies

    Javid J. Moslehi

  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

    Alexander R. Lyon;Susan Dent;Susannah Stanway;Helena Earl

  • Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

    Enrico Ammirati;Maria Frigerio;Eric D. Adler;Cristina Basso

  • Immune checkpoint inhibitors and cardiovascular toxicity.

    Alexander R Lyon;Nadia Yousaf;Nicolò M L Battisti;Javid Moslehi

  • Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement from the American Heart Association

    Robb D. Kociol;Leslie T. Cooper;James C. Fang;Javid J. Moslehi

  • Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

    Javid J. Moslehi;Michael Deininger

  • Cardiovascular toxicities associated with immune checkpoint inhibitors.

    Jiun Ruey Hu;Roberta Florido;Evan J. Lipson;Jarushka Naidoo

  • Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.

    Joe-Elie Salem;Yves Allenbach;Aurore Vozy;Nicolas Brechot

  • High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

    Arun Sharma;Paul W. Burridge;Paul W. Burridge;Wesley L. McKeithan;Wesley L. McKeithan;Ricardo Serrano

  • Roles of interferon-gamma and interleukin-4 in murine lupus

    S L Peng;J Moslehi;J Craft

  • Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology

    Marc P. Bonaca;Benjamin A. Olenchock;Joe Elie Salem;Stephen D. Wiviott

Frequent Co-Authors

Douglas B. Johnson
Douglas B. Johnson Vanderbilt University Medical Center
William G. Kaelin
William G. Kaelin Harvard University
Dan M. Roden
Dan M. Roden Vanderbilt University Medical Center
Christian Funck-Brentano
Christian Funck-Brentano Université Paris Cité
Lee W. Jones
Lee W. Jones Memorial Sloan Kettering Cancer Center
Justin M. Balko
Justin M. Balko Vanderbilt University Medical Center
Phyllis C. Zee
Phyllis C. Zee Northwestern University
Wendy Demark-Wahnefried
Wendy Demark-Wahnefried University of Alabama at Birmingham
Susan Cheng
Susan Cheng Cedars-Sinai Medical Center
Jose G. Montoya
Jose G. Montoya Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare careers beyond traditional medical school, there are numerous flexible academic options available online. Many students start their journey with online nursing programs, which offer a variety of entry points for those seeking a rewarding patient care role. These programs can be more affordable and accessible, especially for those balancing work and study.

For those looking to advance their qualifications, affordable graduate programs have become increasingly popular. Options such as the cheapest dnp programs are ideal for nurses aiming for leadership or specialized positions. Similarly, registered nurses seeking further advancement often choose the cheapest accredited online rn to bsn programs to expand their career potential and earning power.

For those holding a non-nursing bachelor’s degree, direct-entry routes like direct msn programs online can provide a fast track into advanced nursing roles. These online degrees offer flexibility, affordability, and a pathway to diverse healthcare careers, whether you’re starting out or advancing within the medical field.

Best Scientists Citing Javid Moslehi

Trending Scientists

Recently Published Articles